Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  Bristol-Myers Squibb Co    BMY

Delayed Quote. Delayed  - 07/29 03:44:31 pm
64.84 USD   +0.28%
07/28DJMead Johnson to Settle Foreign Corruption Charges
07/27DJReckitt Benckiser First-Half Profit Rises 8%
07/27DJReckitt Benckiser First-Half Profit Up 8% --2nd Update
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/23/2015 07/24/2015 07/27/2015 07/28/2015 07/29/2015 Date
68.24(c) 65.98(c) 64.3(c) 64.66(c) 64.84 Last
8 947 014 6 866 757 9 237 536 9 173 089 4 071 748 Volume
-1.63% -3.31% -2.55% +0.56% +0.28% Change
More quotes
Financials ($)
Sales 2015 15 817 M
EBIT 2015 3 373 M
Net income 2015 2 606 M
Finance 2015 2 170 M
Yield 2015 2,31%
Sales 2016 16 683 M
EBIT 2016 4 124 M
Net income 2016 3 747 M
Finance 2016 2 095 M
Yield 2016 2,38%
PER 2015 47,75
PER 2016 28,40
EV / Sales 2015 6,68x
EV / Sales 2016 6,34x
Capitalization 107 821 M
More Financials
Company
Bristol-Myers Squibb Co. is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products.Its pharmaceutical products include chemically-synthesized drugs or small molecules and an increasing portion of products produced from... 
Sector
Pharmaceuticals
Calendar
10/21Earnings Release
More about the company
Surperformance© ratings of Bristol-Myers Squibb Co
Trading Rating : Investor Rating :
More Ratings
Latest news on BRISTOL-MYERS SQUIBB CO
04:03a BRISTOL MYERS SQUIBB : Secures FDA Approval of Daklinza
04:01a BRISTOL MYERS SQUIBB : Taps JLL for Facility Management
03:55a BRISTOL MYERS SQUIBB : -Myers: European Medicines Agency Validates 2 Parallel Ty..
03:55a BRISTOL MYERS SQUIBB : Releases 2Q Financial Results
07/28DJMead Johnson to Settle Foreign Corruption Charges
07/28 BRISTOL MYERS SQUIBB : Releases 2Q Financial Results
07/28 BRISTOL MYERS SQUIBB : European Medicines Agency Offers Validation to 2 Parallel..
07/28 BRISTOL MYERS SQUIBB : Album launched to promote World Hepatitis Day
More news
Sector news : Pharmaceuticals - NEC
10:28a CATERPILLAR : Dow Movers: CAT, PFE
10:08a FTSE extends gains, Hikma and GlaxoSmithKline support
10:08a PERRIGO : Mylan gets European clearance in proposed Perrigo takeover
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
08:50a Gilead Sciences Beats And Guidance Raise Give It Room To Run Upward
07/28 FDA accepts Merck's NDA for HCV combo grazoprevir/elbasvir
07/28 EXELIXIS : A Buyout Target In The Making
07/28 Boehringer Ingelheim teams up with Hanmi Pharma on 3rd gen EGFR candidate
07/28 WHAT TO EXPECT FROM GILEAD'S 2Q EARN : The Theory Behind The Madness


Comments 
Advertisement
Chart BRISTOL-MYERS SQUIBB CO
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Full-screen chart
Technical analysis trends BRISTOL-MYERS SQU...
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions